mbruvica 140mg Capsule contains Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of several types of blood cancers.
Bottle
Imbruvica 140mg Capsule contains Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of several types of blood cancers. Ibrutinib works by blocking BTK, a protein that helps cancer cells survive and grow. By inhibiting this protein, Imbruvica interferes with the growth and spread of cancer cells, particularly in certain types of leukemia and lymphoma.